R
Roland S. Croner
Researcher at University of Erlangen-Nuremberg
Publications - 22
Citations - 2561
Roland S. Croner is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 16, co-authored 22 publications receiving 1268 citations.
Papers
More filters
Journal ArticleDOI
Hepatic platelet and leukocyte adherence during endotoxemia
Roland S. Croner,Elfie Hoerer,Yakup Kulu,Tilo Hackert,Martha-Maria Gebhard,Christian Herfarth,Ernst Klar +6 more
TL;DR: Hepatic platelet-endothelial interaction is an early event during endotoxemia, which underlines the probable involvement of platelets in leukocyte recruitment and makes the existence of autoregulatory liver mechanisms likely.
Journal ArticleDOI
Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
Monika Julia Wolf,Alexandra Hoos,Judith Bauer,Steffen Boettcher,Markus Knust,Achim Weber,Nicole Simonavicius,Christoph Schneider,Matthias Lang,Michael Stürzl,Roland S. Croner,Andreas Konrad,Markus G. Manz,Holger Moch,Adriano Aguzzi,Geert van Loo,Manolis Pasparakis,Marco Prinz,Lubor Borsig,Mathias Heikenwalder,Mathias Heikenwalder +20 more
TL;DR: CCL2 upregulation in metastatic UICC stage IV colon carcinomas is described and it is demonstrated that tumor cell-derived CCL2 activates the CCR2(+) endothelium to increase vascular permeability in vivo.
Journal Article
Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.
TL;DR: The clinicopathological spectrum of gastrointestinal manifestations of NF-1 including putative proliferative precursor lesions are summarized and discussed with emphasis on the differential diagnostic aspects of these disorders and their molecular pathogenesis.
Journal ArticleDOI
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis
Markus Hecht,Maike Büttner-Herold,Katharina Erlenbach-Wünsch,Marlen Haderlein,Roland S. Croner,Robert Grützmann,Arndt Hartmann,Rainer Fietkau,Luitpold Distel +8 more
TL;DR: Combined low PD-L1 expression on tumour and inflammatory cells is an independent negative prognostic marker for OS in RCT of rectal adenocarcinoma patients, which should prompt clinical trials combining radiotherapy and PD-1/PD-L 1 pathway blockade.
Journal ArticleDOI
Multivisceral resection for colon carcinoma.
Roland S. Croner,Susanne Merkel,Thomas Papadopoulos,Vera Schellerer,Werner Hohenberger,Jonas Goehl +5 more
TL;DR: The high percentage of R0 resections achieved through multivisceral resection justifies this procedure for locally advanced colon carcinomas and highlights the importance of experienced, well-trained surgeons to decrease the incidence of locoregional recurrence.